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Abstract— DNA microarray technology has become a more attractive tool for cancer classification in the scientific and industrial 
fields. Based on the previous researchers, the conventional approach for cancer classification is primarily based on the morphological 
appearance of the tumor. The limitations of this approach are the bias in identify the tumors by expert and faced the difficulty in 
differentiating the cancer subtypes due to most cancers being highly related to the specific biological insight.  Thus, this study 
proposes an improved parallelized Minimum Redundancy Maximum Relevance (mRMR), which is a particularly fast feature 
selection method for finding a set of both relevant and complementary features. The mRMR can identify genes more relevance to the 
biological context that leads to richer biological interpretations. The proposed method is expected to achieve accurate classification 
performance using a small number of predictive genes when tested using two datasets from Cancer Genome Project and compared to 
previous methods. 
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I. INTRODUCTION 
In recent technology in molecular biology especially 
microarray analysis, provide new discoveries in basic 
biology, pharmacology, and medicine which are facilitated 
from whole genome RNA. The gene expression of the cell is 
extremely important to determine its phenotype and function. 
Thus, the advancement technology in molecular biology had 
made the cancer classification become a central topic of 
research in cancer treatment. The classification of a cancer 
determines appropriate treatment and helps to determine the 
prognosis [1].  The cancer classification has faced difficulty 
in part because it relied on specific biological insight rather 
than systematic and unbiased approaches for recognizing the 
cancer cells. The approaches for cancer classification are 
primarily based on the morphological appearance of the 
tumours [2]. The limitations of the conventional approach 
are the bias in identify the tumours by expert and faced the 
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difficulty in differentiating the cancer subtypes due to most 
cancers being highly related to the specific biological insight. 
Therefore, microarray technology has been growing recently 
in order to overcome the limitations in the cancer 
classifications. 
In the recent years, many researchers have observed that 
microarray gene expression data has an important role in 
disease diagnosis helping physicians to choose in advance 
the suitable treatment plan for patients. Recently, biomedical 
studies had faced a few challenges in order to classify the 
samples into two states which are disease or not-disease. 
Due to the challenges, microarray data has become crucial 
because genetic information in the form of microarray data 
can be used to identify and classify a new patient's sample 
into disease or no disease classes. However, considering the 
amount and complexity of the gene expression data, it is 
hard to analyse it manually. Thus, there is a need for 
computational methods. This is a classification problem 
where the task is to learn a classification model based on a 
set of labelled training samples from the two populations, 
and then using learned model to predict the label of test 
(unseen) samples. Each sample is represented in terms of 
numeric values obtained from some gene expression 
measurements. Interpreting gene expression data is not a 
trivial task because gene expression data is high dimensional 
in nature, but its sample size is very low. Gene selection is 
an important sub-problem in such studies. In microarray data, 
the size of feature-set (gene expression levels) is very much 
larger than the training sample size [3]. 
In microarray analysis technology, classification has been 
a well-known approach that is used to obtain a biological 
interpretation from the microarray data, and it plays an 
important role in cancer diagnosis. Basically, in 
classification, microarray dataset is divided into training data 
and testing data where the training data is used to train a 
classifier and this classifier is used to classify the validation 
data into the correct class of sample. Classification of patient 
samples (e.g., tumour or healthy) can be used to predict 
clinical outcome. This is a contrast to the conventional ways 
of cancer diagnosis that based on examination of stained 
tissue specimens by a trained pathologist under light 
microscopy. In recent years, many sophisticated 
computational methods have been developed based on some 
well-established classification algorithms such as support 
vector machine (SVM) by Vapnik [4] and random forest by 
Breiman [5]. Random forest is a decision tree based 
ensemble learning method built for both classification and 
regression while SVM uses a hyperplane with maximized 
margin to separate the given sample classes. SVM has been 
widely used in microarray analysis due to its robustness to 
sparse and noisy data. To that end, a requisite issue in the 
analysis of this kind of data is to find an appropriate 
algorithm for selection of the most important features. 
Due to the high-dimensional characteristics of the 
microarray data that with a large number of genes, it is 
important for the computational methods to select 
informative genes for more robust classifier in order to 
achieve better classification performance [6]. This is known 
as feature selection or more specifically gene selection in the 
field of bioinformatics. Generally, in gene selection, there 
consist of three different gene selection approaches namely 
filter, wrapper and embedded. These approaches 
differentiate with each other based on their way of 
integration. Among these approaches, embedded approach 
integrates the selection method into the classifier, held better 
interaction with the classifier and better computational 
complexity [7]. One of the embedded approaches is the 
hybrid of SVM and smoothly clipped absolute deviation 
(SCAD) that embedded the SCAD penalty function into 
SVM that enabled gene selection within SVM for better 
classification performance [8]. SCAD penalty function was 
first proposed by Fan and Li [9] that provide a nearly 
unbiased estimate for large coefficients. Feature selection 
provides a lot of benefits as it improves prediction 
performance, understandability, scalability, and 
generalization capability of the classifier. It also reduces 
computational complexity and storage, provides faster and 
more cost-effective model [10], and plays an important role 
in knowledge discovery. Moreover, it offers new insights for 
determining the most relevant or informative features [11]. 
Based on the previous researches, cancer is classified by 
the type of cell that the tumour cells resemble and is 
presumed to be the origin of the tumour. Classification of a 
cancer determines appropriate treatment and helps to 
determine the prognosis. Thus, the cancer is classified by 
using mRMR for smaller gene subset selection method by 
the previous researcher. The lack of the mRMR is the fast 
and greedy heuristics but it is not guaranteed to find a global 
optimal solution should one exist. The fundamental problem 
with redundancy is that the feature set is not a 
comprehensive representation of the characteristics of the 
target phenotypes. Moreover, the features selected by a 
single mRMR run are unlikely to sufficient interpretation for 
the variety of the biological processes related to the 
phenotype under study. 
In this research, an improved parallelized mRMR for 
smaller gene subset selection for cancer classification has 
been proposed. This is because mRMR has fast feature 
selection method for finding a set of both relevant and 
complementary features. Among these heuristics, mRMR 
feature selection technique is particularly appealing because 
of the relatively low computational complexity of its 
algorithm for finding the relevant set and the complementary 
features [12]. An ensemble mRMR implementations 
outperform the classical mRMR approach in terms of 
prediction accuracy. Thus mRMR can identify genes more 
relevance to the biological context that leads to richer 
biological interpretations. In addition, the parallelized 
function of mRMR includes in the package of mRMR show 
significant gains in terms of run-time speed when compared 
with previously released package. The benefit of MRMR 
feature set is reduced mutual redundancy within the feature 
set; these features capture the class characteristics in a wider 
scope.   
The diagnosis of a complicated genetic disease like cancer 
is normally based on tumour tissue, irrational characteristics, 
and clinical stages. In treating cancer, early detection can 
dramatically increase the chances of survival. Thus, time 
plays a crucial role in treating the disease. Imaging 
techniques, which are the main method of detection and 
diagnosis, are only useful once the cancerous growth has 
become visible. Another common method used to identify 
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cancer cells is by searching and classifying large amounts of 
genetic data [13]. There are a few approaches that can be 
used for feature selection in cancer classification by using 
Support Vector Machine (SVM), Hybrid GA/SVM, Random 
Forest and Minimum Redundancy Maximum Relevance 
(mRMR). 
In recent years, DNA Microarray technology can measure 
the expression level of a great number of genes in tissue 
samples simultaneously and become promisingly for clinical 
in the form of diagnosis and prediction of clinical outcomes 
of cancer and other complex diseases. Therefore, the 
researcher continuously seeking to develop and finding the 
most accurate classification algorithms for the creation of a 
gene expression patient profile in order to maximize the 
benefits of this technology [14]. Based on Díaz-Uriarte and 
Andrés [15], the most common task in the gene expression 
studies is to select the relevant genes for sample 
classification where the researchers attempt to categorize the 
smallest gene subset selection that can even now accomplish 
great prescient performance (for example, for future use with 
demonstrative purposes in clinical practice). 
Cancer is classified by the type of cell that the tumour 
cells resemble and is presumed to be the origin of the tumour. 
Classification of a cancer determines appropriate treatment 
and helps to determine the prognosis. Thus, the cancer is 
classified by using mRMR for smaller gene subset selection 
method by the previous researcher. The lack of the mRMR is 
the fast and greedy heuristics but it is not guaranteed to find 
a global optimal solution should one exist. The fundamental 
problem with redundancy is that the feature set is not a 
comprehensive representation of the characteristics of the 
target phenotypes [16]-[18]. Moreover, the features selected 
by a single mRMR run are unlikely to sufficiently 
interpretation for the variety of the biological processes 
related with the phenotype under study. 
The mRMRe R package which is the minimum 
redundancy maximum relevance (mRMR) is extended by 
using the ensemble approach in order to better explore the 
feature space and build more robust predictors [19]. The 
ensemble approach had led to computational complexity, 
thus to overcome the problem, the R package is implemented 
and parallelized in C using the OpenMP Application 
Programming Interface. The ensemble mRMR 
implementations outperform the classical mRMR in terms of 
the prediction accuracy. In addition, the run-time speed of 
ensemble mRMR is much better compared to other packages 
because the parallelized function is included in R package. 
The mRMRe implements an ensemble variant of mRMR in 
which multiple feature sets rather than single list features are 
built. The function for computing a mutual information 
matrix (MIM) is included in the package based on the 
appropriate estimators for each variable type (continuous 
discrete and survival data) [19]. Both this package features 
have been adapted to fully use multicore platforms. 
Although mRMR is a fast and greedy heuristic, it is not 
guaranteed to find a global optimal solution should one 
exists. To solve these problems, two ensemble approaches 
had implemented to generate multiple mRMR solutions in 
parallel; these two techniques are referred to as exhaustive 
and bootstrap ensemble mRMR. 
II. MATERIAL AND METHOD 
Based on Table 1, the dataset that had been used in this 
research are obtained by analyzing published 
pharmacogenomics datasets generated by the Cancer 
Genome Project (CGP), the Cancer Cell Lines Encyclopedia 
(CCLE) and CGPS dataset and ALL/AML Leukemia dataset 
are obtained from the website: datam.i2r.a-star.edu.sg/ 
datasets/krbd/. The pre-processing of the raw dataset is 
needed before the data can be used in this research. The 
extension of the formatted file is .rda file. This format is 
needed to ensure it can compute in R package environment. 
Two datasets are used in this research, which are Cancer 
Genome Project CGP and ALL/AML Leukemia dataset. The 
features of the dataset shown include a number of genes and 
number of patients [20]. The CGP dataset consists of 1000 
genes with 100 patients while Leukaemia dataset contains 
7129 genes of 72 patients. 
TABLE I 
MICROARRAY DATASET USED 
Dataset    
Name 
Genes Patients Reference 
CGP 1000 100 [17] 
Leukaemia 7129 72 [18] 
 
The minimum redundancy maximum relevance (mRMR) 
with MIQ and MID scheme is described in detail. The genes 
with significantly different expressions in two different 
classes (normal and tumor or two different subtypes of 
cancer) are called differentially expressed genes. The 
relevance of a gene is referred as the degree of differential 
expression of that gene. The relevance of gene can be 
calculated by mutual information [21], [22]. If the 
expression of a gene has randomly or uniformly distributed 
in different classes, its mutual information with these classes 
is zero. If a gene is strongly differentially expressed for 
different classes, it should have large mutual information. 
Here we consider mutual information for discrete variable 
only. 
The parallelized functions included in the package show 
significant gains in terms of run-time speed when compared 
with previously released packages. The multiple mRMR in 
parallel is generated. These two techniques are referred to as 
exhaustive and bootstrap ensemble mRMR [23]. The 
exhaustive variant enhanced the classical mRMR heuristic 
by initializing multiple feature selection procedures with the 
k41 most relevant features. Subsequently, k mRMR solution 
is produced in parallel, in which the first selected feature is 
guaranteed to be different. The bootstrap variant resamples 
(with replacement) the original dataset to generate k 
bootstraps, and classical mRMR feature selection is 
performed in parallel for each of the bootstrapped datasets, 
thus generating k mRMR solutions [24]-[26]. 
The algorithm that used in this research is maximum 
relevance and minimum redundancy (mRMR) feature 
selection algorithm. The conventional of parallelized mRMR 
method is improved using the maximum relevance and 
minimum redundancy (mRMR) feature selection algorithm. 
The algorithm that had been enhanced will implement by 
using the R package for the best smaller gene subset 
selection for cancer classification [27]. 
1597
In this research, two performance measurements are 
involved to evaluate the effectiveness of proposed method. 
Firstly, the performance measurement is on the classification 
accuracy of mRMR method with Random Forest classifier 
for all microarray datasets. Secondly, the performance 
measurement is based on run-time performances in seconds 
of mRMR by using the CGP dataset. 
 
 =   , 	
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Based on the Equation (1), the set of selected features, 
denoted by S, is then initialized with xi. Next, another 
feature is added to S by choosing the feature having the 
highest relevance with the output variable and the lowest 
redundancy with the previously selected features, thus 
maximizing the score q at step j. Step j is repeated until the 
desired solution length has been attained. This approach had 
been implemented for continuous/survival, and discrete 
variables also referred to as F-test Correlation Difference 
(FCD) and Mutual Information Difference (MID) schemes. 
The OOB rate is calculated by selecting the smallest 
subset of genes with average out of bag (OOB) error rates 
between the smallest number of genes which is two and the 
subset with the number of genes that has the lowest OOB 
error rates. The equation of the OOB rate is shown in 
Equation (2). In the equation, the p resembles the true 
efficiency and n is the sample size. 
 
Standard error =  (1 − ) ∗ " 
 
 
 
Fig. 1  Proposed parallelized mRMR method 
The proposed method is illustrated as in Figure 1. Firstly, 
the sample dataset that had been used in this research is 
obtained by analyzing published pharmacogenomics datasets 
generated by the Cancer Genome Project [CGP; (Garnett et 
al., 2012)] and ALL/AML Leukemia dataset. The dataset is 
downloaded in txt file format (Leukimia.txt). The dataset is 
undergoing several steps to convert it into text file format in 
rda before it can use in R package. All the datasets contain 
two classes of samples [23]. Then, a few parameter is set up 
by assigning to a new name and assign certain value during 
the initializing phase. Next, the initial microarray gene 
expression profiling is Filtered and pre-processed using the 
mRMR gene selection method. Each gene is evaluated and 
sorted using the mRMR mutual information MI operations. 
The highest relevant genes that give 100% classification 
accuracy with Random Forest classifier are identified to 
form a new subset. The mRMR dataset denotes the less 
redundant and more relative genes as selected by the mRMR 
approach. The mRMR is applied to filter the irrelevant and 
noisy genes and reduces the computational load for the 
mRMR algorithm. The parallelized functions included in the 
package show significant gains in terms of run-time speed 
when compared with previously released packages. The 
multiple mRMR in parallel is generated. These two 
techniques are referred as exhaustive and bootstrap ensemble 
mRMR.  The exhaustive variant extended the classical 
mRMR heuristic by initialized multiple feature selection 
procedures with the k41 most relevant features. Next, k 
mRMR solutions are produced in parallel, which the first 
selected feature is guaranteed to be different. The bootstrap 
variant resamples (with replacement) the original dataset to 
generate k bootstraps, and classical mRMR feature selection 
is performed in parallel for each of the bootstrapped datasets, 
thus generating k mRMR solutions. Next, Use the 
informative and predictive genes that are generated from the 
mRMR algorithm in the second phase to train the Random 
Forest classifier. The Random Forest is applied again to 
classify the testing microarray dataset and restore the 
classification accuracy. Lastly, the predictive and 
informative genes are obtained. 
Based on the previous researchers, the mRMR filter 
method does not involve to remove irrelevant genes and 
noisy genes. Thus, the number of gene subset selection 
obtain a large number of genes that lead to computational 
complexity. In this research, the mRMR filter method is 
added in order to remove irrelevant genes at the first stage 
that will reduce the time-consuming. The R package of 
parallelized is used for gene selection process that improves 
the run-time speed when compared with the previous 
packages. Lastly, The Random Forest is applied again to 
classify the testing microarray dataset and restore the 
classification accuracy. The improvement had been made by 
implementing the parallelized mRMR package in R 
environment and added the Random Forest classifier in order 
to calculate the accuracy of the gene subset selection. 
III. RESULTS AND DISCUSSION 
Table 2 shows the total number of genes selected using 
SINGLEGENE, RANK, mRMR and mRMRe. The 
SINGLEGENE selected only one number of gene but the 
gene selected sometimes is not the most informative genes, 
(1) 
(2) 
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and it’s hard to analyze. Next, the total number of genes 
selected by RANK and mRMR is 16 but the value of 
correlation in mRMR greater than RANK. Then, mRMRe 
selected 214 the number of genes. This selected genes is 
large and will increase the computational time.  The gene is 
selected based on the correlation value for each gene. Lastly, 
the improved method had selected only 10 numbers of genes. 
The gene numbers selected is smaller compared to RANK, 
mRMR, and mRMRe. Thus, the computational time is much 
smaller than others.  The IC50 is used to measure the 
sensitivity to detect the cancer cells. This measured 
sensitivity (IC50) detected Irinotecan (Camptothecin), a 
therapeutic drug mainly used in colon cancer. This metric is 
applied to discriminate between resistant and sensitive cell 
lines. 
TABLE II 
GENE SUBSET SELECTION [12]  
Methods Gene Selection 
SINGLEGENE Total number of genes selection =1 
RANK Total number of genes selection =16 
mRMR Total number of genes selection =16 
mRMRe Total number of genes selection =214 
Improved method Total number of genes selection =10 
In this experimental result, the classification has been 
carried out based on the smallest subset of genes selected in 
the gene selection process as illustrated in Table 3. The 
selection is based on the smallest subset of genes with lowest 
out of bag (OOB) error rates. Based on Table 3, the OOB 
rate for CGPS dataset is 0.06 and 0.02 for leukaemia dataset. 
A smaller value indicates higher prediction accuracy, so 
lower values are better. In random forests, there is no need 
for cross-validation or a separate test set to get an unbiased 
estimate of the test set error. It is estimated internally, during 
the run, as follows: 
     Each tree is constructed using a different boot-strap 
sample from the original data. About one-third of the cases 
are left out of the bootstrap sample and not used in the 
construction of the kth tree. Put each case left out in the 
construction of the kth tree down the kth tree to get a 
classification. In this way, a test set classification is obtained 
for each case in about one-third of the trees. 
TABLE III 
OOB RATE 
Dataset    Name OOB Rate 
CGP 0.06 
Leukaemia 0.02 
 Classic function of mRMR allows an efficient selection 
of relevant and non-redundant features. The method ranks X 
by maximizing the MI with y (maximum relevance) and 
minimizing the average MI with all the previously selected 
variables (minimum redundancy). The runtime values below 
indicate the performance of mRMR. Table 4 shows the 
runtime using the system in seconds. The lower value 
indicates the best value that leads to lower computational 
time. The lower value of runtime because of the smaller 
gene subset selection. The computational time of the existing 
mRMR method by using CGPS dataset is 28s while the 
improved method only takes 2s to execute the system. The 
leukaemia dataset is added to test on the computational run 
time. The time taken to execute the system is 7s.  
TABLE IV 
    RUN TIME(S) 
Dataset Existing mRMR Improved 
mRMR 
CGP 28 2 
Leukaemia - 7 
 
The experiment result and analysis has been discussed, 
where the detailed result has been provided according to 
based on selection method. The result and discussion of each 
enhanced technique used to achieve the target result have 
been populated in order to display the differences as well as 
the improvement achieved. The enhancement method which 
is a selection of the smallest subset of genes with the lowest 
OOB error rates.  
IV. CONCLUSION 
The improved parallelized mRMR method helps to 
overcome the limitations of the original single mRMR 
method. Thus, it helps in faster convergence in the 
conventional single mRMR and contributes in shorten the 
computational time as well as increase the accuracy of the 
smaller gene subset selection in cancer classification.  In 
addition, the maximum relevance and minimum redundancy 
(mRMR) feature selection algorithm also contributes to 
reducing the noise data. The parallelized mRMR method 
helps in shortens the computation time compared to the 
conventional single method. Therefore, the maximum 
relevance and minimum redundancy (mRMR) feature 
selection algorithm and parallelized mRMR method increase 
the accuracy if the smaller subset of genes selection for 
cancer classification in this research [28], [29]. 
The difficulties in doing this research are the dataset is 
complicated since the dataset required to undergoes pre-
processing data before it is used in this research. Thus, for 
the future works, the dataset should be provided in several 
types of file format or reduced the complexity of the dataset 
for reducing the time-consuming in pre-processing data. On 
the other hand, the dataset that contains high-dimensional or 
complexity can be used to experiment to obtain the accuracy 
result of the smaller gene subset selection for the cancer 
classification. In addition, the proposed method can be used 
for the smaller gene subset selection in cancer classification 
for the large dataset. Moreover, a comparison of current 
hybrid methods and the proposed method for observing the 
differences performance and accuracy of the methods. The t-
test can measure the performance of the proposed methods 
in the future. For the future work, try to reduce the inter-
subset distance of the features, expecting to find the best 
compact gene array which has the most effect on the target 
classes due to classification task which is a supreme lead in 
the diagnosis of tragic diseases, e.g., cancers [30]. The 
further research of mRMR can be a focus on datasets with 
multiple-class labels. Other statistical measurements such as 
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information gain, the chi-square test can be considered for 
gene ranking. Hybrid approaches of optimization may be 
implemented with an improved solution which can be 
suggested to avoid premature convergence [30]. 
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